BioNTech

BioNTech sticks with cancer vaccine despite trial miss pharmaphorum12:24Pfizer Vaccine Cancer Treatment HPV

BioNTech misses PFS endpoints in Phase II/III cancer vaccine trial Clinical Trials Arena03:51mRNA Pfizer Vaccine Pharma

Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside? The Motley Fool11:03Moderna mRNA Global Stock Markets

BioNTech mRNA Therapy Plus Keytruda Missed Its Tumor Progression Goal in HPV-Linked Head and Neck Cancer Medical Daily22:45mRNA Cancer Cancer Treatment

Why is BioNTech stock falling Tuesday? Benzinga12:12Nasdaq mRNA Cancer Treatment

BioNTech has more cancer drugs in late-stage trials than most investors realize. Is it a buy under $100? The Motley Fool12:39Pfizer Vaccine Pharma

Moderna is now worth more than 3X as much as BioNTech. Which biotech stock is the smarter pick? The Motley Fool05:06Moderna mRNA Biotechnology

BioNTech closes four sites after failed sale process as post-Covid vaccine sales slump Manufacturing Chemist08:01Coronavirus Vaccine Pfizer Vaccine Covid

Syndax pharmaceuticals, BioNTech, seagate and other big stocks moving lower in Tuesday’s pre-market session Benzinga08:06Global Stock Markets Dow Jones Pharma

BioNTech's BNT113 misses progression-free survival endpoint in phase 3 head and neck cancer trial RTT News07:46HPV Pharma Biotech

Latest News

Yesterday

BioNTech mRNA Therapy Plus Keytruda Missed Its Tumor Progression Goal in HPV-Linked Head and Neck Cancer Medical Daily22:45 14-Oct-26

BioNTech misses PFS endpoints in Phase II/III cancer vaccine trial Clinical Trials Arena03:51 14-Oct-26

In the last 7 days

BioNTech Moves AHEAD With BNT113 Despite Co-Primary Endpoint Miss Scrip Pharma Intelligence17:23 13-Oct-26

BioNTech sticks with cancer vaccine despite trial miss pharmaphorum12:24 13-Oct-26

Why Is BioNTech Stock Falling Tuesday? Benzinga12:12 13-Oct-26

Syndax Pharmaceuticals, BioNTech, Seagate And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session Benzinga08:06 13-Oct-26

BioNTech's BNT113 Misses Progression-Free Survival Endpoint In Phase 3 Head And Neck Cancer Trial RTT News07:46 13-Oct-26

BioNTech Continues ahead-merit Trial Despite BNT113's PFS Endpoint Miss RTT News07:35 13-Oct-26

Moderna Is Now Worth More Than 3X as Much as BioNTech. Which Biotech Stock Is the Smarter Pick? The Motley Fool05:06 13-Oct-26

BioNTech Has More Cancer Drugs in Late-Stage Trials Than Most Investors Realize. Is It a Buy Under $100? The Motley Fool12:39 8-Oct-26

In the last month

Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? Zacks13:10 30-Sep-26

BioNTech closes four sites after failed sale process as post-COVID vaccine sales slump Manufacturing Chemist08:01 29-Sep-26

Can Vaccine Approval Change The Bull Case For BioNTech (BNTX)? Simply Wall St21:56 28-Sep-26

BioNTech to close three German sites The New Times12:26 28-Sep-26

Moderna vs. BioNTech: Which mRNA Cancer Stock Has More Upside? The Motley Fool11:03 28-Sep-26

BioNTech (NasdaqGS:BNTX) Stock May Look Fully Valued On Fresh Lung Cancer Trial Data Simply Wall St06:03 25-Sep-26

BioNTech co-founders name new pharmaceutical company ‘Arife’ Hurriyet Daily News04:51 25-Sep-26

Which Is the Bigger Story for BioNTech -- Its Colorectal Cancer Vaccine Setback or the Lung Cancer Clinical Success? The Motley Fool17:42 22-Sep-26

BioNTech Stock Recently Got Downgraded. But Is Wall Street Underestimating Its Cancer Pipeline? The Motley Fool05:00 22-Sep-26

BioNTech Threw in the Towel on Its Colorectal Cancer Vaccine Trial. Should Investors Be Worried? The Motley Fool05:00 18-Sep-26

WCLC 2026: BioNTech’s Gotistobart Looks Closer To Big Win In NSCLC Scrip Pharma Intelligence13:05 15-Sep-26

New lung cancer drug lifts survival versus chemotherapy Los Angeles Times10:13 15-Sep-26

BioNTech says lung cancer drug candidate nearly doubles survival Daily Sabah08:13 15-Sep-26

BioNTech and OncoC4 report median OS data from RESERVE-003 Phase III trial Clinical Trials Arena06:04 15-Sep-26

WCLC: Lung cancer news from BioNTech, Akeso, and Roche pharmaphorum05:28 15-Sep-26

Why Is BioNTech Stock Gaining Monday? Benzinga10:41 14-Sep-26

view more headlines

14 Oct 22:45

About our BioNTech news

Latest news on BioNTech, a German biotechnology company that makes active immunotherapies for patient-specific approaches to the treatment of diseases.

Publication filters

Sorry, no headlines or news topics were found. Please try different keywords.